UrgoStart Plus NA Lipido-Colloid Sucrose-Octasulfate Polyfibrous Foam Dressing 15x20cm

Also available in SKU/Size,

100440 / 6x6cm, 100441 / 10x10cm, 100442 / 15x20cm

A soft-adherent TLC-NOSF matrix is combined with polyacrylate poly-absorbent fibres, which guarantee wound cleaning.

Key Features:

• Healing properties
• Comfort and ease of use

Benefits:

• Reduction of healing time combined with cleaning (slough, exudate, debris).
• Absorption of exudate
• Management of minor bleeding wounds
• Creation and maintenance of a moist wound environment that promotes healing
• Atraumatic removal
• Protection of peri-wound skin
• Pain free removal
• One piece removal of the dressing
• Very comfortable and easy to reposition

Indications:

UrgoStart Plus NA is indicated for all stages (from the desloughing stage to complete healing) of:

• Exuding wounds
• Chronic wounds
  • Leg ulcers
  • Pressure injuries
  • Diabetic foot ulcers
• Long standing acute wounds.

Contraindications:

• UrgoStart Plus NA facilitates the management of minor bleeding wounds. However it should not be used for heavily bleeding wounds.
• In order not to delay any optimal treatment, UrgoStart Plus NA is contra-indicated in cancerous wounds and wounds which may reveal a deep abscess.
• Do not use when there is a known sensitivity to UrgoStart Plus NA.

Precautions:

• The soft-adherent layer of UrgoStart Plus NA adheres to latex surgical gloves. Therefore it is recommended that the tabs be used to facilitate application of the dressing.
• As it includes a super-absorbent layer, UrgoStart Plus NA should not be cut.
• If the wound shows signs of local infection, it is recommended that anti-microbial treatment is used first before starting treatment with UrgoStart Plus NA.
• If an atypical ulcer presents induration or over-granulation, treatment with UrgoStart Plus NA should only be initiated after verifying that ulcer deterioration is absent, to prevent any delay in diagnosis.
• In the absence of clinical data regarding Epidermolysis Bullosa (even for longstanding lesions), the use of UrgoStart Plus NA is not recommended.
• Stinging or even painful sensations may be reported at the start of the treatment. These are usually linked to the healing process and the need to suspend treatment is rare.
• During desloughing, the wound may appear to get larger due to the gradual elimination of slough.
• Concomitant use with a cream, an ointment, an emulsion is not recommended.
• UrgoStart Plus NA must not be used in a hyperbaric chamber.
• Sterile individual packaging, for single use only: re-using a disposable dressing can lead to the risks of infection.
  • Do not re-sterilise the dressing.
  • (*) Check that the sterile protector is intact before use. Do not use if package is damaged.

*This product image is only for reference.